Company profile for Erasca

Erasca

NEW Drugs in Dev: 7

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

pharmacompass-1-m-2026-04-20

Contact Supplier

AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

pharmacompass-2-m-2026-04-20

Contact Supplier

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

119 News #PharmaBuzz

media
119 News #PharmaBuzz

DEVELOPMENTS

37 Drugs in Development

37 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Erasca is a clinical-stage precision oncology company driven by a bold mission—to erase cancer. We are on a journey to shut down one of cancer’s most commonly mutated signaling cascades, the RAS/MAPK pathway, which affects approximately 5.5 million lives each year worldwide. Our promising pipeline targets the RAS/MAPK pathway at virtually every turn, endowing us with the potential to make a transformative difference in the...

Erasca is a clinical-stage precision oncology company driven by a bold mission—to erase cancer. We are on a journey to shut down one of cancer’s most commonly mutated signaling cascades, the RAS/MAPK pathway, which affects approximately 5.5 million lives each year worldwide. Our promising pipeline targets the RAS/MAPK pathway at virtually every turn, endowing us with the potential to make a transformative difference in the treatment and lives of people suffering from a wide range of devastating cancers—bringing hope, where there was little, that the future can be brighter and cancer free.

PEGS Boston SummitPEGS Boston Summit

Not Confirmed

Not Confirmed

11 May-15 November, 2026

Massachusetts, U.S.A
Pharmex Middle EastPharmex Middle East

Not Confirmed

Not Confirmed

26-28 May, 2026

Tehran, Iran
UK Biotech DayUK Biotech Day

Not Confirmed

Not Confirmed

27-28 May, 2026

London, U.K

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

United_States_of_America Flag

Country

Country

U.S.A

Address

Address

Erasca, Inc. 10835 Road to the Cure Suite 140 San Diego, CA 92121

Telephone

Telephone

Email

enquiries@pharmacompass.com

Client Website

Website

https://www.erasca.com/

Linkedin

youtube

YouTube

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Can Immuneering, Actuate Top Revolution's Pancreatic Cancer Drug?

18 May 2026

// BIOSPACE

Erasca Updates Q1 2026 Business And Financial Results

11 May 2026

// GLOBENEWSWIRE

Revolution Issues Legal Threat to Erasca as Rivalry Heats

29 Apr 2026

// BIOSPACE

Erasca Reports RAS Cancer Drug Data After Legal Threat

27 Apr 2026

// ENDPOINTS

Erasca To Present Phase 1 Data On ERAS-0015 In Conference Call

27 Apr 2026

// GLOBENEWSWIRE

Erasca Updates 2025 Q4 Business Updates And Financial Results

12 Mar 2026

// GLOBENEWSWIRE

Drugs in Development

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Market Place

Home

Menu

Post Enquiry

Market Place

Search